Company / Operating Cash Flow
ARVINAS, INC. Operating Cash Flow History
FY2017-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Operating Cash Flow
-$273.8M
FY2025
5-year range
-$347.8M / -$40.6M
FY2021-FY2025
Trend
-5.6%
vs FY2024
Sector context
#186 of 216
Health Care
What the data says
ARVINAS, INC.'s operating cash flow of -$274M is lower than 86% of companies in the Health Care sector (FY2025). Operating Cash Flow has fluctuated over the past 9 years, ranging from -$348M in FY2023 to $5M in FY2017.
Based on SEC 10-K filings.
-$274M in FY2025.
Improved from -$348M to -$274M over the past 2 years.
Health Care sector context is included.
Operating Cash Flow over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
Bottom 14% in Health CareTop 86% of 216This company -$273.8M Sector average $658.7M
▼
-141.6% below sector average
Key checks
Key Insights
- In FY2025, operating cash flow decreased 5.6% year-over-year.
- Ranks #186 out of 216 companies in the Health Care sector.
- Peak operating cash flow was recorded in FY2017.
- Lowest operating cash flow in the period was in FY2023.
Company context
Key Data Points
- Altman Z-Score -0.85 (distress zone, below 1.8 threshold)
- Low earnings quality (accrual-heavy earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Operating Cash FlowValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | -$273.8M | -5.6% |
| FY2024 | -$259.3M | +25.4% |
| FY2023 | -$347.8M | -287.7% |
| FY2022 | -$89.7M | -120.9% |
| FY2021 | -$40.6M | +54.7% |
| FY2020 | -$89.7M | -456.5% |
| FY2019 | -$16.1M | +0.0% |
| FY2018 | -$16.1M | -415.2% |
| FY2017 | $5.1M | - |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026